Bonterra is a Canadian gold exploration company with a large balanced portfolio of exploration and mining assets. Bonterra controls the only permitted gold mill in the region with a large land position of approximately 35,000 hectares in the Urban Barry Camp. Bonterra is located in the mining-friendly province of Quebec, within the Abitibi Greenstone Belt. The company was founded in 2007 by Johnny Oliveira.
Viseon is a privately held medical device company committed to developing proprietary technology for use in Minimally Invasive Spine Surgery (MISS) procedures. Viseon has progressed rapidly over the past 6-months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive spine surgery procedures. In addition to rapid product development of its initial products, Viseon has assembled a world-class Scientific Advisory Board of leading MISS physicians, amassed 13 patents to solidify its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon. Viseon was founded in early 2017 as a spin-out from Rebound Therapeutics Corporation.
AZTherapies is an advanced clinical-stage biopharmaceutical company developing novel therapies that aim to fundamentally change neurodegenerative disease progression, extending normal cognition and function and improving quality of life in the aging population. Advancing a growing pipeline to treat patients with few therapeutic options, the Company’s lead candidate, ALZT-OP1, is built on a multi-modal approach that recognizes neuroinflammation as a root cause of serious neurodegeneration and seeks to stop or slow the progression of the disease. The Phase 3 COGNITE trial in early Alzheimer’s disease is fully enrolled and expected to complete in late 2020. Following the lead program, AZTherapies is advancing candidates for the treatment of post-ischemic stroke cognitive impairment, amyotrophic lateral sclerosis (ALS), and other indications. AZTherapies is a private company founded in 2011 and headquartered in Boston, Massachusetts.
Specialty Renal Products, a subsidiary of Nephros, is focused on the development of medical device products for patients with renal disease, including a hemodiafiltration system for the treatment of patients with ESRD.SRP intends to develop and market a filtration system for use in conjunction with the disposable tubing circuit sets used in treatments that provide continuous renal replacement therapy (CRRT). The system will apply to patients who present in the intensive care unit with acute kidney injury (AKI). CRRT allows the clinician the ability to manage unstable AKI patients by offering slower ultrafiltration and solute removal. Some advantages with performing CRRT continuously (24 hours per day) include improved hemodynamic tolerance and more control over the total volumes given and removed from unstable AKI patients.
Viseon is a privately held medical device company committed to developing proprietary technology for use in Minimally Invasive Spine Surgery (MISS) procedures. Viseon has progressed rapidly over the past 6-months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive spine surgery procedures. In addition to rapid product development of its initial products, Viseon has assembled a world-class Scientific Advisory Board of leading MISS physicians, amassed 13 patents to solidify its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon. Viseon was founded in early 2017 as a spin-out from Rebound Therapeutics Corporation.
Shape Memory Medical Inc is a medical device company based in Santa Clara, California, founded to commercialize innovative medical devices based on Shape Memory Polymer (SMP) materials that were developed at Texas A&M University and Lawrence Livermore National Laboratory. The company is dedicated to developing innovative therapeutic solutions for peripheral vascular, cardiovascular, and neurovascular markets. Shape Memory Medical's device is the first to introduce an FDA-cleared medical device utilizing shape memory polymer (SMP) technology to a vascular market, enabling physicians to improve patient care. The Shape Memory Medical team has extensive experience with the SMP foam technology and the commercialization of medical devices.
Rebound has progressed rapidly over the past 18 months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgical procedures. In addition to rapid product development of its initial products, Rebound has assembled a world-class Scientific Advisory Board of leading MIS physicians, filed 14 patents to solidify its intellectual property platform and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.
ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.
Vantage Sports is reinventing the way that sports teams, media and fans gather, analyze, and use data. The team are creating tools for the most extensive and visionary data set in the history of sports and they are looking to hire passionate talent. Vantage Sports is a provider of a data collection platform designed to reinvent the way that sports teams, media and fans gather, analyze, and use data. The company's data collection platform tracks the statistics of athletes and franchises in the NBA beyond standard statistical categories and offers the data to the required personnel, enabling clients to have complete and enhanced data analytics.
Dig Inn is a restaurant inspired by the seasons and the act of cooking. Classic recipes with lots of vegetables, expertly prepared, and sourced mindfully from farmers and producers we know and trust. Whether you’re looking for whole grains, naturally-raised meats, or fresh veggies, we’ve got a bowl with your name on it.
Private Equity Round in 2013
OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.
Sophono is a medical device manufacturer specializing in implantable, bone conduction hearing devices. The company’s products are designed for individuals suffering from severe to profound hearing loss or impairment. Treating those with conductive hearing loss, mixed hearing loss, and single-ear deafness, the FDA-cleared product Alpha 1 eliminates the problematic abutment of devices by using magnets to affix external sound processors.
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.
Ellipse Technologies is focused on developing its implantable remote control technology platforms to include innovative treatments for a broad spectrum of spinal and orthopedic deformity applications, orthopedic trauma and fracture management. The initial products restore proper anatomic position and alignment of the spine and long-bones. MAGECâ„¢ MAGnetic Expansion Control System utilizes a novel motion-preserving, minimally-invasive technology that, through communication with an external magnetic field, can be non-invasively adjusted in an outpatient setting via remote control by the physician to correct spinal deformities. PRECICE System uses non-invasive adjustable intramedullary rods or bone plates to treat long-bone abnormalities, often the result of acute or chronic fractures. Ellipse is a privately-held medical device company located in California.
Reverse Medical is a commercial-stage medical device company focused on revascularizing patients who experience acute ischemic strokes.
International Battery (IB) is a green technology company providing environmentally friendly, large format, rechargeable lithium-ion cells and batteries — designed, developed and manufactured in the USA. IB provides next generation cell chemistries, electronics and advanced packaging technologies, broad design experience, and offers total solutions for rechargeable battery applications. There batteries can be used in a wide range of vehicular, industrial and military applications.
Infinia Corporation is a solar energy technology company and the developer of the PowerDish, a proprietary solar power generation product that converts solar energy into electricity. The PowerDish is expected to be sold globally beginning in late 2010 and will be initially sold to energy asset developers, utilities, commercial companies and others engaged in deploying large scale solar asset projects.
Infinia Corporation is a solar energy technology company and the developer of the PowerDish, a proprietary solar power generation product that converts solar energy into electricity. The PowerDish is expected to be sold globally beginning in late 2010 and will be initially sold to energy asset developers, utilities, commercial companies and others engaged in deploying large scale solar asset projects.
GlobeImmune, operates as a biopharmaceutical company. It engages in developing and manufacturing Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Its products include GI-3000, a Tarmogen for epidermal growth factor receptor over expressing tumors; GI-4000, a Tarmogen for mutated-Ras mediated cancers; GI-5005, a Tarmogen for chronic hepatitis C infection; GI-8000, a Tarmogen for influenza; and GI-10000 Targeted Ablation of Mutational Escape, a novel use of the Tarmogen platform that eliminates or prevents the emergence of mutated escape variants in patients receiving antiviral or targeted cancer therapies. GlobeImmune was founded in 1995 as Ceres Pharmaceuticals, Inc. The company is based in Louisville, Colorado.
Interventional Spine®, Inc. was founded in February 2000 to solve a key problem confronting surgeons: how to address the aging population and resulting increase of fractures in patients with osteoporotic bone? Fracture fixation devices available at the time had severe limitations when used in the presence of osteoporotic bone. Interventional Spine product development was grounded on the basis of the Company's Compression (CLASP®) technology, which provides effective fixation in both normal and osteoporotic bone. Due to the superior fracture fixation characteristics of the CLASP® technology, Interventional Spine originally designed devices for the Podiatric and Orthopedic Trauma markets, successfully implanting over 4,000 Orthopedic Trauma Products in patients. The technology enabled surgeons to change the way they managed bone fractures, allowing for precise positioning with compression independent of thread movement, while providing superior pullout resistance and compression when compared to traditional lag screws. This proven and patented technology forms the basis of Interventional Spine's existing products.
Epiphany Biosciences is developing both therapeutic products and diagnostic technologies that treat or prevent the spread of pathogenic viruses. Epiphany Biosciences is a privately-held company located in San Francisco, CA. To support its mission, Epiphany has assembled a world-class team of virologists, clinicians, and drug development experts with extensive pharmaceutical business experience to lead the company forward.
ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Their proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. They then leverage their unparalleled technical expertise and government funding to address other emerging challenges of their time ranging from a cleaner environment, alternative energy to life science.
Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.
Private Equity Round in 2005
Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.
As the vanguard of distributed energy control, Encorp leverages the power of its advanced Gold Box™ to harness diverse forms of generation in today's New Energy Economy. Their energy-tech offerings and grid interconnection expertise advance energy savings, security and efficiency for federal, institutional and commercial installations. Their technologies transform the electric grid into a system that is cleaner, more cost effective, efficient, flexible, reliable, resilient and responsive. Encorp's elegant software and hardware seamlessly integrate a variety of distributed power resources, such as engine-generator sets, microturbines, fuel cells, combined heat and power (CHP or cogeneration), and energy storage devices. These power resources are critical in the operation of any enterprise that demands high-quality, reliable power at reasonable and predictable costs.
NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.